⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Redbird Research and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Redbird Research
↗Las Vegas, USA
Redbird Research is a dedicated clinical research site focused on advancing treatment options for psychiatric and central nervous system (CNS) conditions. The organization specializes in conducting safe, ethical, and IRB-approved clinical trials to shape the future of mental health care.
Led by industry experts, the company leverages extensive experience in CNS research to execute studies with precision and scientific integrity. They are committed to making clinical research more accessible and inclusive for communities, with a strong focus on psychiatric disorders including schizophrenia, bipolar disorder, and depression.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Clinical Research Site / CNS Therapeutics
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Clinical Research Site)
Active Trials:21
Trial Phases:Phase 2: 10 | Phase 3: 10 | Phase 4: 1
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Jelena Kunovac - Co-Founder and CEO
Scientific Founders:Jelena Kunovac
LINKS
Website:kunovacmd.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Redbird Research. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.